02914, East Providence, Rhode Island Breast Cancer Score Travel Score

The Travel Score for the Breast Cancer Score in 02914, East Providence, Rhode Island is 74 when comparing 34,000 ZIP Codes in the United States.

80.11 percent of residents in 02914 to travel to work in 30 minutes or less.

When looking at the three closest hospitals, the average distance to a hospital is 2.14 miles. The closest hospital with an emergency room is Emma Pendleton Bradley Hospital with a distance of 1.61 miles from the area.

**Breast Cancer Score: Navigating Healthcare in 02914**

The journey to healthcare, particularly for those facing a breast cancer diagnosis, is a complex one. It extends far beyond the walls of a clinic or hospital, encompassing the very fabric of a patient's daily life, including the crucial element of transportation. In the heart of East Providence, Rhode Island, ZIP code 02914 presents a unique landscape for healthcare access, demanding a careful assessment of its transportation infrastructure. This analysis aims to provide a "Breast Cancer Score" – a comprehensive overview of the available transportation options for residents in this area, considering the specific needs of those undergoing breast cancer treatment and the challenges they may face.

The score considers drive times, public transit accessibility, ride-sharing availability, and specialized medical transport services. It's a crucial factor for anyone considering moving to East Providence, particularly those with pre-existing health concerns.

**Driving the Distance: A Road Map to Care**

For many residents of 02914, the automobile remains the primary mode of transportation. Navigating the local roads and highways is essential for accessing healthcare facilities. The proximity to major thoroughfares like Interstate 195 (I-195) and Route 1A (Newport Avenue) significantly impacts drive times to various medical centers.

To reach the closest major hospitals, such as Rhode Island Hospital in Providence, drivers typically utilize I-195 West. The drive, depending on traffic, usually takes between 10 to 20 minutes. For those seeking care at Women & Infants Hospital, also in Providence, the journey is similar, often involving I-195 West. The time frame is the same.

Accessing the Lifespan Cancer Institute, a crucial resource for breast cancer patients, is generally straightforward. However, the notorious traffic congestion during peak hours, especially on I-195, can significantly extend travel times.

Route 1A, which runs through East Providence, offers an alternative route, especially for destinations further east or for avoiding highway backups. However, this route can be slower due to traffic lights and local congestion.

Understanding these drive times is paramount for patients. The added stress of a long commute, especially during treatment, can be debilitating. The Breast Cancer Score must factor in the reliability and efficiency of these driving routes.

**Public Transit: A Network of Challenges and Opportunities**

For those without access to a personal vehicle, public transportation plays a vital role in healthcare access. The Rhode Island Public Transit Authority (RIPTA) provides bus service throughout the state, including 02914. However, the accessibility and efficiency of RIPTA routes can significantly impact a patient's ability to attend appointments.

Several RIPTA routes serve the East Providence area. The number 1, 3, and 60 buses are particularly relevant, offering connections to Providence and access to various medical facilities. The number 1 bus, in particular, runs along North Broadway and provides access to the East Providence Senior Center.

The accessibility of these routes is a critical consideration. RIPTA is mandated to provide ADA-accessible buses, featuring ramps and other accommodations for individuals with disabilities. However, the frequency of service, especially during off-peak hours and weekends, can be a significant barrier. Long wait times and the potential for multiple transfers can be exhausting for patients undergoing treatment.

The Breast Cancer Score must account for the availability of accessible routes, the frequency of service, and the overall convenience of public transit options for patients in 02914.

**Ride-Sharing and Medical Transport: Bridging the Gap**

Ride-sharing services like Uber and Lyft offer another transportation alternative. Their availability in the Providence metropolitan area is generally good, providing on-demand transportation to and from medical appointments. However, the cost of these services can be a significant financial burden, particularly for patients who require frequent trips.

Specialized medical transport services cater specifically to the needs of patients with medical conditions. These services often provide door-to-door transportation, including assistance with mobility and other needs. Companies like MedRide and First Transit offer medical transportation services in the Providence area.

The Breast Cancer Score must consider the availability, cost, and accessibility of ride-sharing and medical transport services. These options can be crucial for patients who cannot drive or who require assistance with mobility.

**The Breast Cancer Score: A Holistic Assessment**

The "Breast Cancer Score" for 02914 is not a single number but a multifaceted evaluation. It requires a comprehensive assessment of all transportation options, considering drive times, public transit accessibility, ride-sharing availability, and medical transport services.

The score must also factor in the specific needs of breast cancer patients, including the potential for fatigue, mobility limitations, and the emotional toll of treatment. The ideal score would reflect a community that prioritizes healthcare access by providing convenient, affordable, and accessible transportation options.

For those considering moving to East Providence, this score is a critical piece of information. It helps individuals make informed decisions about their healthcare access and ensures they have the support they need to navigate the challenges of breast cancer treatment.